Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
This study will look at the relationships between inflammation, infection, and lung structure and function over a 4 year period. Infants diagnosed with CF by newborn screening will receive annual measurements from birth to age of 4 years. This study will allow investigators to describe in the first years of life factors that may predict early onset of bronchiectasis. Tests include infant and preschool pulmonary function tests, chest CT scans, and bronchoscopies annually.
14 Days - 4 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.